Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escalating Dose Indomethacin for Persistent PDA
NCT00750581Phase 3Terminated
- Sponsor
- University of Calgary
- Start
- Aug 2008
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in patent ductus arteriosus (PDA), sponsored by University of Calgary. Started Aug 2008; status: terminated.
02
Drugs
indomethacin
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT00750581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750581.